Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate

Pacing Clin Electrophysiol. 2002 May;25(5):871-2. doi: 10.1046/j.1460-9592.2002.00871.x.

Abstract

Treatment of paroxysmal atrial fibrillation with flecainide acetate resulted in a 4-fold increase in ventricular capture thresholds. The detailed time course of the threshold increase and decrease was documented using the AutoCapture algorithm and graphic summary.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Arrhythmia Agents / adverse effects*
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / therapy*
  • Equipment Failure
  • Flecainide / adverse effects*
  • Flecainide / therapeutic use
  • Heart Ventricles / physiopathology*
  • Humans
  • Male
  • Pacemaker, Artificial*

Substances

  • Anti-Arrhythmia Agents
  • Flecainide